Found: 4
Select item for more details and to access through your institution.
Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease: Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 4, p. 542, doi. 10.1111/apt.18144
- By:
- Publication type:
- Article
Editorial: ARFI‐based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity—A prospective biopsy‐controlled study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 1, p. 70, doi. 10.1111/apt.18019
- By:
- Publication type:
- Article
Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 11, p. 1376, doi. 10.1111/apt.17945
- By:
- Publication type:
- Article